This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.

Introduction.- Part 1 Theoretical and conceptual approaches to ethics in antimicrobial resistance.- Chapter 1 The practical ethics of antimicrobial resistance as a collective action problem (Julian Savulescu).- Chapter 2 Collective responsibility for antimicrobial resistance (Angus Dawson).- Chapter 3 Moral aspects of antimicrobial stewardship (Marcel Verweij).- Chapter 4 Ethical frameworks for rational antibiotic use (Annette Rid, Jasper Littmann, Alena Buyx).- Chapter 5 The virtuous physician as antimicrobial prescriber (Justin Oakley).- Chapter 6 Solidarity and compliance with antimicrobial policy (Søren Holm, Thomas Ploug).- Chapter 7 Resistance, inequality, and epidemiological transition (Lynette Reid).- Chapter 8 The price of precaution (Joakim Larsson, Christian Munthe).- Part 2 Ethics and antimicrobial resistance in context.- Chapter 9 Hospital acquired infection (Lyn Gilbert & Ian Kerridge).- Chapter 10 Antibiotic use in childhood (Michael Millar).- Chapter 11 Ethics, animals, public goods (Jonny Anomaly).- Chapter 12 Malaria (PY Cheah& Mike Parker).- Chapter 13 Resistant HIV (Bridget Haire).- Chapter 14 Access & availability of new TB drugs (Diego Silva, Adrian Viens, Jasper Littmann).- Chapter 15 TB Resistance and Human rights (Leslie London).- Chapter 16 TB Resistance in developing countries (Richard Coker, Marco Liverani, Mishal Khan).- Chapter 17 Animal Epidemiology (Lisa Boden & Dominic Mellor).- Part 3 Ethical, legal and economic aspects of antimicrobial resistance.- Chapter 18 Privacy and  data collection(Leslie Francis).- Chapter 19 Mandatory treatment  interventions (Carl Coleman).- Chapter 20 Ethics and AMR Regulation (Belinda Bennett).- Chapter 21 Ethics of Drug Development (Nick King).- Chapter 22 Economics of resistance (Coast/Smith).- Conclusion.